By Dhirendra Tripathi
Investing.com – Moderna (NASDAQ:MRNA) and BioNTech stocks (NASDAQ:BNTX) slumped by 15% each Wednesday on a report that Europe’s drug regulator is studying three new conditions reported by a small number of people after vaccination with Covid-19 shots to assess if they may be possible side-effects.
The conditions were reported in patients who took the mRNA vaccines made by either Moderna or BioNTech-Pfizer.
Pfizer stock fell 3%. Expenses and profit from the Covid…
Source link
